检索结果 - Jeremy Force

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
    Mechanisms of Therapeutic Antitumor Monoclonal Antibodies

    Mechanisms of Therapeutic Antitumor Monoclonal Antibodies 由 Li-Chung Tsao, Jeremy Force, Zachary C. Hartman

    出版 2021
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Clinical trials of self-replicating RNA-based cancer vaccines

    Clinical trials of self-replicating RNA-based cancer vaccines 由 Michael A. Morse, Erika J. Crosby, Jeremy Force, Takuya Osada, Amy Hobeika, Zachary C. Hartman, Peter Berglund, Jonathan Smith, H. Kim Lyerly

    出版 2023
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Differential Effects of Vascular Endothelial Growth Factor Receptor-2 Inhibitor ZD6474 on Circulating Endothelial Progenitors and Mature Circulating Endothelial Cells: Implications for Use as a Surrogate Marker of Antiangiogenic Activity

    Differential Effects of Vascular Endothelial Growth Factor Receptor-2 Inhibitor ZD6474 on Circulating Endothelial Progenitors and Mature Circulating Endothelial Cells: Implications... 由 Paul Beaudry, Jeremy Force, George N. Naumov, Andrew Wang, Cheryl H. Baker, Anderson J. Ryan, Shay Söker, Bruce E. Johnson, Judah Folkman, John V. Heymach

    出版 2005
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database

    Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database 由 Cecilia T. Ong, Brittany M. Campbell, Samantha M. Thomas, Rachel A. Greenup, Jennifer K. Plichta, Laura H. Rosenberger, Jeremy Force, Allison Hall, Terry Hyslop, E. Shelley Hwang, Oluwadamilola M. Fayanju

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT)

    The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT) 由 Oluwadamilola M. Fayanju, Yi Ren, Samantha M. Thomas, Rachel A. Greenup, Jennifer K. Plichta, Laura H. Rosenberger, Nina Tamirisa, Jeremy Force, Judy C. Boughey, Terry Hyslop, E. Shelley Hwang

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence

    RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence 由 Chao‐Chieh Lin, Nathaniel W. Mabe, Yi-Tzu Lin, Wen‐Hsuan Yang, Xiaohu Tang, Lisa Hong, Tianai Sun, Jeremy Force, Jeffrey R. Marks, Tso‐Pang Yao, James V. Alvarez, Jen‐Tsan Chi

    出版 2020
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    APOBEC Mutagenesis Inhibits Breast Cancer Growth through Induction of T cell–Mediated Antitumor Immune Responses

    APOBEC Mutagenesis Inhibits Breast Cancer Growth through Induction of T cell–Mediated Antitumor Immune Responses 由 Ashley V. DiMarco, Xiaodi Qin, Brock J. McKinney, Nina Marie G. Garcia, Sarah C. Van Alsten, Elizabeth A. Mendes, Jeremy Force, Brent A. Hanks, Melissa A. Troester, Kouros Owzar, Jichun Xie, James V. Alvarez

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Evaluation of KRAS Mutations, Angiogenic Biomarkers, and DCE-MRI in Patients with Advanced Non–Small-Cell Lung Cancer Receiving Sorafenib

    Evaluation of KRAS Mutations, Angiogenic Biomarkers, and DCE-MRI in Patients with Advanced Non–Small-Cell Lung Cancer Receiving Sorafenib 由 Ronan J. Kelly, Arun Rajan, Jeremy Force, Ariel López-Chávez, Corrine Keen, Liang Cao, Yunkai Yu, Peter L. Choyke, Barış Türkbey, Mark Raffeld, Liqiang Xi, Seth M. Steinberg, James R. Wright, Shivaani Kummar, Martin Gutierrez, Giuseppe Giaccone

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Regression of Drug-Resistant Lung Cancer by the Combination of Rosiglitazone and Carboplatin

    Regression of Drug-Resistant Lung Cancer by the Combination of Rosiglitazone and Carboplatin 由 Geoffrey D. Girnun, Liang Chen, Jessica M. Silvaggi, Ronny Drapkin, Lucian R. Chirieac, Robert F. Padera, Rabi Upadhyay, Scott B. Vafai, Ralph Weissleder, Umar Mahmood, Elnaz Naseri, Stephanie Buckley, Danan Li, Jeremy Force, Kate McNamara, George D. Demetri, Bruce M. Spiegelman, Kwok‐Kin Wong

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013

    A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013 由 Foluso O. Ademuyiwa, Feng Gao, Cherease R. Street, Ina Chen, Donald W. Northfelt, Robert Wesolowski, Mili Arora, Adam Brufsky, Elizabeth Claire Dees, Cesar A. Santa‐Maria, Roisín M. Connolly, Jeremy Force, Alvaro Moreno‐Aspitia, John M. Herndon, Madelyn Carmody, Sherri R. Davies, Sarah Larson, Kathleen L. Pfaff, Stephanie Jones, Jason L. Weirather, Anita Giobbie‐Hurder, Scott J. Rodig, Zheng Liu, Ian S. Hagemann, Elad Sharon, William E. Gillanders

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer

    Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer 由 Erika J. Crosby, Chaitanya R. Acharya, Anthony-Fayez Haddad, Christopher A. Rabiola, Gangjun Lei, Jun-Ping Wei, Xiaoyi Yang, Tao Wang, Cong-Xiao Liu, Kay‐Uwe Wagner, William J. Muller, Lewis A. Chodosh, Gloria Broadwater, Terry Hyslop, Jonathan H. Shepherd, Daniel P. Hollern, Xiaping He, Charles M. Perou, Shengjie Chai, Benjamin K. Ashby, Benjamin G. Vincent, Joshua C. Snyder, Jeremy Force, Michael A. Morse, H. Kim Lyerly, Zachary C. Hartman

    出版 2020
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

    Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030 由 Heather A. Parsons, Timothy Blewett, Xun Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong, Vandana G. Abramson, Ayan R. Patel, Justin Cheng, Adam Brufsky, Justin Rhoades, Jeremy Force, Rong Liu, Tiffany A. Traina, Lisa A. Carey, Mothaffar F. Rimawi, Kathy D. Miller, Vered Stearns, Jennifer M. Specht, Carla I. Falkson, Harold J. Burstein, Antonio C. Wolff, Eric P. Winer, Nabihah Tayob, Ian E. Krop, G. Mike Makrigiorgos, Todd R. Golub, Erica L. Mayer, Viktor A. Adalsteinsson

    出版 2023
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: